Aligos Therapeutics (ALGS) just unveiled an update.
Matthew McClure has stepped down from his role as Chief Medical Officer at Aligos Therapeutics, Inc., marking a significant change in the company’s leadership team. This move could potentially impact investors and stakeholders who follow the company’s executive lineup and strategic direction.
For an in-depth examination of ALGS stock, go to TipRanks’ Stock Analysis page.
